Senior Statistical Analyst (at the rank of Technical Manager)
University of Hong Kong
- Department
- Department of Medicine, School of Clinical Medicine (20600)
- Rank
- Non-Academic
- Position type
- Full-time
- Reference
- 534866
- Application deadline
- 7 May 2026
Duties & Responsibilities
- Lead statistical design, analysis, and interpretation of oncology clinical trials and observational research studies.
- Provide expert statistical consultation on study design, sample size calculations, randomization procedures, and data analysis plans.
- Analyze complex datasets including clinical trial data, genomic data, and electronic health records using advanced statistical methods.
- Develop, implement, and validate reproducible statistical pipelines and workflows.
- Contribute to research manuscripts, grant proposals, and regulatory submissions with statistical rigor.
- Supervise and mentor junior statistical analysts and research staff.
- Collaborate with investigators to translate research findings into clinical practice and publications.
Requirements & Qualifications
- Master's degree or above in Biostatistics, Statistics, Bioinformatics, Epidemiology, or related discipline.
- At least 5 years of post-qualification experience in medical, academic, or clinical research settings.
- Specialization in oncology or clinical trial statistics is highly preferred.
- Strong technical skills in R, SAS, or STATA; proficiency in Python or Linux is advantageous.
- Solid understanding of clinical trial methodologies, survival analysis, longitudinal data analysis, and high-dimensional data.
- Demonstrated track record of leading research projects and co-authoring peer-reviewed publications.
- Excellent written and spoken English communication skills.
- Self-motivated, proactive, capable of independent and collaborative work in multidisciplinary teams.
Appointment
- Full-time fixed-term contract for 2–3 years, commencing as soon as possible, with possibility of renewal subject to satisfactory performance.
Key Dates
- Application review start date: April 21, 2026